Insurers, accountable care organizations, and manufacturers increasingly look for demonstrable clinical outcomes as proof for reimbursement or access to limited distribution networks.
Brandon Newman, PharmD, MMHC, CSP
Advertisement
Articles by Brandon Newman, PharmD, MMHC, CSP
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Pharmacy Times
1
GLP-1 Receptor Agonists Show Promise Across Alcohol, Opioid, and Tobacco Use Disorders
2
Young Women With Symptomatic Long COVID At Higher Risk of POTS
3
Breaking News: CVS Buys Rite Aid, Bartell Drugs
4
OpEd: The Drug Enforcement Administration Needs a Chief Pharmacy Officer. Here’s Why
5
